|
BEX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.00609528988593E-11 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.63180580159406E-12 |
| Stage1-vs-Stage2 |
1.874790E-01 |
| Stage1-vs-Stage3 |
1.936060E-02 |
| Stage1-vs-Stage4 |
5.559500E-03 |
| Stage2-vs-Stage3 |
7.170800E-01 |
| Stage2-vs-Stage4 |
3.123200E-01 |
| Stage3-vs-Stage4 |
4.264000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.00539999999361E-05 |
| Normal-vs-Asian |
2.85400036936778E-10 |
| Caucasian-vs-AfricanAmerican |
1.630780E-01 |
| Caucasian-vs-Asian |
5.218200E-02 |
| AfricanAmerican-vs-Asian |
8.612400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.732200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.55431223447522E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.68010000000307E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.357800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.476260E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.177600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.383760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.307200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.986400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.998600E-03 |
| Classical-VS-Follicular |
7.692800E-01 |
| Classical-VS-Other |
9.814800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.115900E-03 |
| Tall-VS-Other |
1.253550E-01 |
| Tall-VS-Normal |
1.69675384853463E-12 |
| Follicular-VS-Other |
9.122800E-01 |
| Follicular-VS-Normal |
6.34620023198806E-10 |
| Other-VS-Normal |
7.352900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.44169137633799E-15 |
| Normal-vs-N1 |
5.72875080706581E-14 |
| N0-vs-N1 |
2.190600E-01 |
|
|
